SB-240563

anti-IL-5 monoclonal antibody

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SB-240563, covering 2011-01-24 to 2011-01-24. Get the full timeline:

Most recent: Clinical Trial Update: The Prednisone-sparing Effect of Anti-IL-5 Antibody (SB-240563) [Phase 2]